Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,015,136
+$60,340 QoQ
Shares Held
19,239
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#348
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAIRFIELD, BUSH & CO. holds $16,010,185 across 9 Drug Manufacturers - General names. NVS ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,869 | $3,441,164 | |
| 2 | NVS |
Novartis AG
This page
|
19,239 | $3,015,136 | |
| 3 | MRK |
Merck & Co., Inc.
|
20,842 | $2,678,197 | |
| 4 | JNJ |
Johnson & Johnson
|
8,732 | $2,217,666 | |
| 5 | ABBV |
AbbVie Inc.
|
7,031 | $1,769,280 | |
| 6 | AMGN |
Amgen Inc
|
2,933 | $1,062,097 | |
| 7 | NVO |
Novo Nordisk A S
|
18,073 | $866,419 | |
| 8 | PFE |
Pfizer Inc
|
29,294 | $705,399 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,015,136 | 19,239 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,954,796 | 19,344 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,979,784 | 21,613 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,930,796 | 22,854 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,931,346 | 24,224 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,792,796 | 25,052 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,482,961 | 25,516 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,869,633 | 24,949 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,046,565 | 28,617 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,786,694 | 28,809 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,969,729 | 29,412 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,395,604 | 33,336 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,120,760 | 40,836 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,791,412 | 41,211 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,061,800 | 33,750 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,587,532 | 34,042 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $3,139,866 | 37,145 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,652,418 | 41,623 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,635,690 | 41,565 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $4,341,700 | 53,090 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,647,208 | 61,894 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,556,456 | 65,003 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,195,835 | 65,613 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,705,706 | 65,613 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $5,734,133 | 65,653 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,419,603 | 65,732 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||